




已阅读5页,还剩34页未读, 继续免费阅读
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
About this Database Back to Search Page Search Results for: hypromelloseINACTIVEINGREDIENTROUTE;DOSAGE FORMCASNUMBERUNIIMAXIMUMPOTENCYHYPROMELLOSE 2208 (15000 MPA.S)ORAL; CAPSULEZ78RG6M2N280.25MGHYPROMELLOSE 2208 (15000 MPA.S)ORAL; CAPSULE, SUSTAINED ACTIONZ78RG6M2N2336MGHYPROMELLOSE 2208 (15000 MPA.S)ORAL; CAPSULE, SUSTAINED ACTION, HARD GELATINZ78RG6M2N22.771MGHYPROMELLOSE 2208 (15000 MPA.S)ORAL; TABLETZ78RG6M2N286MGHYPROMELLOSE 2208 (15000 MPA.S)ORAL; TABLET, COATEDZ78RG6M2N233MGHYPROMELLOSE 2208 (15000 MPA.S)ORAL; TABLET, CONTROLLED RELEASEZ78RG6M2N27.8MGHYPROMELLOSE 2208 (15000 MPA.S)ORAL; TABLET, EXTENDED RELEASEZ78RG6M2N2320MGHYPROMELLOSE 2208 (15000 MPA.S)ORAL; TABLET, SUSTAINED ACTIONZ78RG6M2N2480MGHYPROMELLOSE 2208 (15000 MPA.S)ORAL; TABLET, SUSTAINED ACTION, COATEDZ78RG6M2N294MGHYPROMELLOSE 2208 (15000 MPA.S)ORAL; TABLET, SUSTAINED ACTION, FILM COATEDZ78RG6M2N2200MGHYPROMELLOSE 2208 (15000 MPA.S)VAGINAL; EMULSION, CREAMZ78RG6M2N20.3%HYPROMELLOSE 2208 (60000 MPA.S)ORAL; TABLET, EXTENDED RELEASE2F7T07H9ZD175MGHYPROMELLOSE 2208 (80000-120000 CPS)ORAL; TABLET, EXTENDED RELEASE9004653VM7F0B23ZI54MGHYPROMELLOSE 2910 (15 MPA.S)ORAL; TABLET36SFW2JZ0W52.5MGHYPROMELLOSE 2910 (15000 MPA.S)NASAL; SOLUTION, SPRAY288VBX44JC0.1%HYPROMELLOSE 2910 (15000 MPA.S)NASAL; SPRAY288VBX44JC0.1%HYPROMELLOSE 2910 (15000 MPA.S)NASAL; SPRAY, METERED288VBX44JC0.1%HYPROMELLOSE 2910 (15000 MPA.S)OPHTHALMIC; SOLUTION288VBX44JC0.5%HYPROMELLOSE 2910 (15000 MPA.S)OPHTHALMIC; SUSPENSION288VBX44JC0.5%HYPROMELLOSE 2910 (15000 MPA.S)OPHTHALMIC; SUSPENSION, DROPS288VBX44JC0.5%HYPROMELLOSE 2910 (15000 MPA.S)ORAL; CAPSULE288VBX44JC40.5519MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; CAPSULE, DELAYED ACTION288VBX44JC33.42MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; CAPSULE, ENTERIC COATED PELLETS288VBX44JC13.82MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; CAPSULE, EXTENDED RELEASE288VBX44JC10.6MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; CAPSULE, HARD GELATIN288VBX44JC2MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; CAPSULE, SUSTAINED ACTION288VBX44JC10.88MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; CAPSULE, SUSTAINED ACTION, HARD GELATIN288VBX44JC4.772MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; GRANULE, FOR ORAL SUSPENSION288VBX44JC26.6MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; POWDER, FOR RECONSTITUTION288VBX44JC1.593%HYPROMELLOSE 2910 (15000 MPA.S)ORAL; POWDER, FOR SUSPENSION288VBX44JC3%HYPROMELLOSE 2910 (15000 MPA.S)ORAL; SOLUTION, SYRUP288VBX44JC2.4%HYPROMELLOSE 2910 (15000 MPA.S)ORAL; SUSPENSION288VBX44JC0.5%HYPROMELLOSE 2910 (15000 MPA.S)ORAL; SYRUP288VBX44JC2.25%HYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET288VBX44JC54MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET (IMMED./COMP. RELEASE), FILM COATED288VBX44JC16.76MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE288VBX44JC11.8MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET, COATED288VBX44JC29.25MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET, CONTROLLED RELEASE288VBX44JC20MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET, DELAYED ACTION288VBX44JC4.47MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET, DELAYED ACTION, ENTERIC COATED288VBX44JC19MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET, ENTERIC COATED PARTICLES288VBX44JC445MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET, EXTENDED RELEASE288VBX44JC150MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET, FILM COATED288VBX44JC60MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET, MULTILAYER, COATED288VBX44JC22MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE288VBX44JC7MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET, SUSTAINED ACTION288VBX44JC250MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET, SUSTAINED ACTION, COATED288VBX44JC6MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL; TABLET, SUSTAINED ACTION, FILM COATED288VBX44JC54MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL-21; TABLET288VBX44JC0.75MGHYPROMELLOSE 2910 (15000 MPA.S)ORAL-28; TABLET288VBX44JC0.75MGHYPROMELLOSE 2910 (5 MPA.S)ORAL; TABLETR75537T0T42.02MGHYPROMELLOSE 2910 (6 MPA.S)ORAL; TABLET0WZ8WG20P64.51MGHYPROMELLOSE 2910 (6 MPA.S)ORAL; TABLET (IMMED./COMP. RELEASE), FILM COATED0WZ8WG20P66.43MGHYPROMELLOSE PHTHALATEORAL; CAPSULE9050311N/A16.8MGHYPROMELLOSE PHTHALATEORAL; CAPSULE, COATED PELLETS9050311N/A13.26MGHYPROMELLOSE PHTHALATEORAL; CAPSULE, ENTERIC COATED PELLETS9050311N/A97.2MGHYPROMELLOSE PHTHALATEORAL; CAPSULE, EXTENDED RELEASE9050311N/A37.8MGHYPROMELLOSE PHTHALATEORAL; CAPSULE, SUSTAINED ACTION9050311N/A19.63MGHYPROMELLOSE PHTHALATEORAL; GRANULE, FOR SUSPENSION9050311N/A302.4MGHYPROMELLOSE PHTHALATEORAL; TABLET9050311N/A104.4MGHYPROMELLOSE PHTHALATEORAL; TABLET, DELAYED ACTION9050311N/A12.7MGHYPROMELLOSE PHTHALATEORAL; TABLET, DELAYED ACTION, ENTERIC COATED9050311N/A44.57MGHYPROMELLOSE PHTHALATEORAL; TABLET, ENTERIC COATED PARTICLES9050311N/A119.4MGHYPROMELLOSESBUCCAL; TABLET3NXW29V3WO24MGHYPROMELLOSESIRRIGATION; SOLUTION3NXW29V3WOHYPROMELLOSESOPHTHALMIC; GEL3NXW29V3WO2.25%HYPROMELLOSESOPHTHALMIC; SOLUTION3NXW29V3WO50%HYPROMELLOSESOPHTHALMIC; SOLUTION, DROPS3NXW29V3WO0.6%HYPROMELLOSESOPHTHALMIC; SUSPENSION3NXW29V3WO0.5%HYPROMELLOSESOPHTHALMIC; SUSPENSION, DROPS3NXW29V3WO0.6%HYPROMELLOSESORAL; CAPSULE3NXW29V3WO150MGHYPROMELLOSESORAL; CAPSULE, COATED PELLETS3NXW29V3WO3.32MGHYPROMELLOSESORAL; CAPSULE, DELAYED ACTION3NXW29V3WO6.808MGHYPROMELLOSESORAL; CAPSULE, DELAYED ACTION, COATED, HARD GELATIN3NXW29V3WO20MGHYPROMELLOSESORAL; CAPSULE, DELAYED ACTION, ENTERIC COATED, SOFT GELATIN3NXW29V3WOHYPROMELLOSESORAL; CAPSULE, ENTERIC COATED PELLETS3NXW29V3WO39.664MGHYPROMELLOSESORAL; CAPSULE, EXTENDED RELEASE3NXW29V3WO79.4MGHYPROMELLOSESORAL; CAPSULE, HARD GELATIN3NXW29V3WO73.9MGHYPROMELLOSESORAL; CAPSULE, SUSTAINED ACTION3NXW29V3WO670.04MGHYPROMELLOSESORAL; CONCENTRATE3NXW29V3WOHYPROMELLOSESORAL; DROPS3NXW29V3WO0.13%HYPROMELLOSESORAL; GRANULE, ENTERIC COATED3NXW29V3WO17.2MGHYPROMELLOSESORAL; GRANULE, FOR ORAL SUSPENSION3NXW29V3WO6.7MGHYPROMELLOSESORAL; MUCILAGE3NXW29V3WO6.03MGHYPROMELLOSESORAL; POWDER, FOR ORAL SUSPENSION3NXW29V3WO7.5%HYPROMELLOSESORAL; POWDER, FOR RECONSTITUTION3NXW29V3WO15%HYPROMELLOSESORAL; POWDER, FOR SUSPENSION3NXW29V3WO6.5%HYPROMELLOSESORAL; SOLUTION3NXW29V3WO0.37%HYPROMELLOSESORAL; SUSPENSION3NXW29V3WO3%HYPROMELLOSESORAL; SUSPENSION, LIQUID3NXW29V3WO2.5%HYPROMELLOSESORAL; SYRUP3NXW29V3WO18%HYPROMELLOSESORAL; TABLET3NXW29V3WO444.4MGHYPROMELLOSESORAL; TABLET (IMMED./COMP. RELEASE), COATED3NXW29V3WO4MGHYPROMELLOSESORAL; TABLET (IMMED./COMP. RELEASE), FILM COATED3NXW29V3WO16MGHYPROMELLOSESORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE3NXW29V3WO10MGHYPROMELLOSESORAL; TABLET, COATED3NXW29V3WO245MGHYPROMELLOSESORAL; TABLET, CONTROLLED RELEASE3NXW29V3WO65.7MGHYPROMELLOSESORAL; TABLET, DELAYED ACTION, ENTERIC COATED3NXW29V3WO127.29MGHYPROMELLOSESORAL; TABLET, EXTENDED RELEASE3NXW29V3WO400MGHYPROMELLOSESORAL; TABLET, FILM COATED3NXW29V3WO536.8MGHYPROMELLOSESORAL; TABLET, MULTILAYER, EXTENDED RELEASE3NXW29V3WO8.4MGHYPROMELLOSESORAL; TABLET, ORALLY DISINTEGRATING3NXW29V3WO6.11MGHYPROMELLOSESORAL; TABLET, REPEAT ACTION3NXW29V3WO60MGHYPROMELLOSESORAL; TABLET, SUSTAINED ACTION3NXW29V3WO400MGHYPROMELLOSESORAL; TABLET, SUSTAINED ACTION, COATED3NXW29V3WO221MGHYPROMELLOSESORAL; TABLET, SUSTAINED ACTION, FILM COATED3NXW29V3WO58.333MGHYPROMELLOSESORAL; TABLET, SUSTAINED RELEASE, FILM COATED3NXW29V3WO300MGHYPROMELLOSESORAL-21; TABLET3NXW29V3WO8MGHYPROMELLOSESORAL-21; TABLET, COATED3NXW29V3WO8MGHYPROMELLOSESORAL-28; TABLET3NXW29V3WO8MGHYPROMELLOSESORAL-28; TABLET, COATED3NXW29V3WO8MGHYPROMELLOSESRECTAL; GEL3NXW29V3WO4.35%HYPROMELLOSESTOPICAL; EMULSION, CREAM3NXW29V3WO0.1%HYPROMELLOSESTOPICAL; EMULSION, LOTION3NXW29V3WO0.1%HYPROMELLOSESTOPICAL; JELLY3NXW29V3WO2.5%HYPROMELLOSESTOPICAL; LOTION3NXW29V3WO0.1%HYPROMELLOSESTOPICAL; PATCH3NXW29V3WO12.14MGHYPROMELLOSESTOPICAL; SOLUTION, DROPS3NXW29V3WO0.105%HYPROMELLOSESVAGINAL; GEL3NXW29V3WO3.5%HYPROMELLOSESVAGINAL; TABLET3NXW29V3WO5MGHYPROMELLOSESVAGINAL; TABLET, FILM COATED3NXW29V3WO54.212MGSearch Results for: lactoseINACTIVEINGREDIENTROUTE;DOSAGE FORMCASNUMBERUNIIMAXIMUMPOTENCYANHYDROUS LACTOSEBUCCAL; TABLET634233SY5LH9PMK23.75MGANHYDROUS LACTOSEIM - IV; INJECTABLE634233SY5LH9PMK2.5%ANHYDROUS LACTOSEIM - IV; POWDER, FOR INJECTION SOLUTION634233SY5LH9PMK2.5%ANHYDROUS LACTOSEINTRACAVITARY; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED634233SY5LH9PMK4.75%ANHYDROUS LACTOSEINTRAVENOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED634233SY5LH9PMK28.75%ANHYDROUS LACTOSEIV(INFUSION); POWDER, FOR INJECTION SOLUTION634233SY5LH9PMK2.5%ANHYDROUS LACTOSEORAL; CAPSULE634233SY5LH9PMK402.5MGANHYDROUS LACTOSEORAL; CAPSULE, COATED, SOFT GELATIN634233SY5LH9PMK71.906MGANHYDROUS LACTOSEORAL; CAPSULE, ENTERIC COATED PELLETS634233SY5LH9PMK117MGANHYDROUS LACTOSEORAL; CAPSULE, HARD GELATIN634233SY5LH9PMK238.24MGANHYDROUS LACTOSEORAL; CAPSULE, SUSTAINED ACTION634233SY5LH9PMK300.8MGANHYDROUS LACTOSEORAL; GRANULE634233SY5LH9PMK433MGANHYDROUS LACTOSEORAL; GRANULE, FOR RECONSTITUTION634233SY5LH9PMK15.688MGANHYDROUS LACTOSEORAL; POWDER, FOR INHALATION634233SY5LH9PMK0.1161%ANHYDROUS LACTOSEORAL; TABLET634233SY5LH9PMK735.2MGANHYDROUS LACTOSEORAL; TABLET (IMMED./COMP. RELEASE), COATED634233SY5LH9PMK93.3MGANHYDROUS LACTOSEORAL; TABLET (IMMED./COMP. RELEASE), FILM COATED634233SY5LH9PMK126.3MGANHYDROUS LACTOSEORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL634233SY5LH9PMK98.7MGANHYDROUS LACTOSEORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE634233SY5LH9PMK108MGANHYDROUS LACTOSEORAL; TABLET, COATED634233SY5LH9PMK144.192MGANHYDROUS LACTOSEORAL; TABLET, DELAYED ACTION, ENTERIC COATED634233SY5LH9PMK90MGANHYDROUS LACTOSEORAL; TABLET, FILM COATED634233SY5LH9PMK453.6MGANHYDROUS LACTOSEORAL; TABLET, SUSTAINED ACTION634233SY5LH9PMK180.9MGANHYDROUS LACTOSEORAL; TABLET, SUSTAINED ACTION, COATED634233SY5LH9PMK130.7MGANHYDROUS LACTOSEORAL; TABLET, SUSTAINED ACTION, FILM COATED634233SY5LH9PMK157.95MGANHYDROUS LACTOSEORAL-21; TABLET634233SY5LH9PMK75.687MGANHYDROUS LACTOSEORAL-21; TABLET, COATED634233SY5LH9PMK58MGANHYDROUS LACTOSEORAL-28; TABLET634233SY5LH9PMK79.335MGANHYDROUS LACTOSEORAL-28; TABLET, COATED634233SY5LH9PMK58MGANHYDROUS LACTOSESUBLINGUAL; TABLET634233SY5LH9PMK128MGANHYDROUS LACTOSEVAGINAL; TABLET634233SY5LH9PMK605MGEPILACTOSEORAL; SOLUTION504685693515BNP80920%EPILACTOSERECTAL; SOLUTION504685693515BNP80920%GALACTOSEORAL; POWDER, FOR SOLUTION3646739X2RN3Q8DNEGALACTOSEORAL; SOLUTION3646739X2RN3Q8DNE90%GALACTOSEORAL; TABLET3646739X2RN3Q8DNE0.665MGGALACTOSERECTAL; SOLUTION3646739X2RN3Q8DNE90%LACTOSEBUCCAL/SUBLINGUAL; TABLET63423J2B2A4N98G296.7MGLACTOSEBUCCAL; TABLET63423J2B2A4N98G183.3MGLACTOSEIM - IV - SC; INJECTION63423J2B2A4N98GLACTOSEIM - IV - SC; POWDER, FOR INJECTION SOLUTION63423J2B2A4N98G13.3%LACTOSEIM - IV; INJECTION63423J2B2A4N98GLACTOSEIM - IV; POWDER, FOR INJECTION SOLUTION63423J2B2A4N98GLACTOSEINHALATION; CAPSULE63423J2B2A4N98G20MGLACTOSEINHALATION; CAPSULE, HARD GELATIN63423J2B2A4N98G25MGLACTOSEINHALATION; POWDER63423J2B2A4N98G9%LACTOSEINTRACAVITARY; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED63423J2B2A4N98G19.38%LACTOSEINTRAMUSCULAR; INJECTION63423J2B2A4N98GLACTOSEINTRAMUSCULAR; POWDER, FOR INJECTION SOLUTION63423J2B2A4N98G2%LACTOSEINTRAMUSCULAR; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED63423J2B2A4N98G1%LACTOSEINTRAVENOUS; INJECTION63423J2B2A4N98G50%LACTOSEINTRAVENOUS; POWDER, FOR INJECTION SOLUTION63423J2B2A4N98G5%LACTOSEINTRAVENOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED63423J2B2A4N98G1%LACTOSEIV(INFUSION); INJECTION63423J2B2A4N98GLACTOSEIV(INFUSION); POWDER, FOR INJECTION SOLUTION63423J2B2A4N98GLACTOSEIV(INFUSION); SOLUTION, INJECTION63423J2B2A4N98G0.45%LACTOSEORAL; CAPSULE63423J2B2A4N98G530MGLACTOSEORAL; CAPSULE, COATED PELLETS63423J2B2A4N98G102.44MGLACTOSEORAL; CAPSULE, ENTERIC COATED PELLETS63423J2B2A4N98G135.2MGLACTOSEORAL; CAPSULE, HARD GELATIN63423J2B2A4N98G100MGLACTOSEORAL; CAPSULE, SOFT GELATIN63423J2B2A4N98G115.75MGLACTOSEORAL; CAPSULE, SUSTAINED ACTION63423J2B2A4N98G120MGLACTOSEORAL; CONCENTRATE63423J2B2A4N98GLACTOSEORAL; GRANULE63423J2B2A4N98GLACTOSEORAL; GRANULE, FOR SUSPENSION63423J2B2A4N98GLACTOSEORAL; POWDER, FOR SOLUTION63423J2B2A4N98GLACTOSEORAL; SOLUTION63423J2B2A4N98G90%LACTOSEORAL; TABLET63423J2B2A4N98G1020MGLACTOSEORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE63423J2B2A4N98G117.7MGLACTOSEORAL; TABLET, COATED63423J2B2A4N98G332.05MGLACTOSEORAL; TABLET, CONTROLLED RELEASE63423J2B2A4N98G69.25MGLACTOSEORAL; TABLET, DELAYED ACTION63423J2B2A4N98G92.02MGLACTOSEORAL; TABLET, DELAYED ACTION, ENTERIC COATED63423J2B2A4N98G209MGLACTOSEORAL; TABLET, DELAYED RELEASE63423J2B2A4N98GLACTOSEORAL; TABLET, FILM COATED63423J2B2A4N98G590MGLACTOSEORAL; TABLET, MULTILAYER, EXTENDED RELEASE63423J2B2A4N98G122MGLACTOSEORAL; TABLET, REPEAT ACTION63423J2B2A4N98G153.2MGLACTOSEORAL; TABLET, SUSTAINED ACTION63423J2B2A4N98G400MGLACTOSEORAL; TABLET, SUSTAINED ACTION, FILM COATED63423J2B2A4N98G51.1MGLACTOSEORAL; TABLET, SUSTAINED RELEASE, FILM COATED63423J2B2A4N98G38.75MGLACTOSEORAL-20; TABLET63423J2B2A4N98G70.7MGLACTOSEORAL-21; TABLET63423J2B2A4N98G89.275MGLACTOSEORAL-28; TABLET63423J2B2A4N98G179.2MGLACTOSERECTAL; SOLUTION63423J2B2A4N98G90%LACTOSERECTAL; TABLET63423J2B2A4N98G65.3816MGLACTOSESUBCUTANEOUS; POWDER, FOR INJECTION SOLUTION63423J2B2A4N98G2%LACTOSESUBCUTANEOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED63423J2B2A4N98G0.5%LACTOSESUBLINGUAL; TABLET63423J2B2A4N98G175.92MGLACTOSETRANSDERMAL; FILM, CONTROLLED RELEASE63423J2B2A4N98G675MGLACTOSETRANSDERMAL; OINTMENT63423J2B2A4N98G18.9%LACTOSEVAGINAL; EMULSION, CREAM63423J2B2A4N98G3%LACTOSEVAGINAL; SUPPOSITORY63423J2B2A4N98GLACTOSEVAGINAL; TABLET63423J2B2A4N98G1013MGLACTOSE MONOHYDRATEBUCCAL; TABLET64044515EWQ57Q8I5X21.375MGLACTOSE MONOHYDRATEIM - IV - SC; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED64044515EWQ57Q8I5X10.7%LACTOSE MONOHYDRATEIM - IV; POWDER64044515EWQ57Q8I5X2.75%LACTOSE MONOHYDRATEIM - SC; INJECTION64044515EWQ57Q8I5X2.1%LACTOSE MONOHYDRATEINTRACAVITARY; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED64044515EWQ57Q8I5X4.54%LACTOSE MONOHYDRATEINTRAMUSCULAR; INJECTION64044515EWQ57Q8I5X5%LACTOSE MONOHYDRATEINTRAVENOUS; INJECTION64044515EWQ57Q8I5X90%LACTOSE MONOHYDRATEINTRAVENOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED64044515EWQ57Q8I5X69%LACTOSE MONOHYDRATEIV - SC; INJECTION64044515EWQ57Q8I5X4.9%LACTOSE MONOHYDRATEIV(INFUSION); POWDER, FOR INJECTION SOLUTION64044515EWQ57Q8I5X20%LACTOSE MONOHYDRATEIV(INFUSION); POWDER, FOR INJECTION SOLUTION, LYOPHILIZED64044515EWQ57Q8I5X90%LACTOSE MONOHYDRATEIV(INFUSION); POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED64044515EWQ57Q8I5XLACTOSE MONOHYDRATEORAL; CAPSULE64044515EWQ57Q8I5X427.26MGLACTOSE MONOHYDRATEORAL; CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN64044515EWQ57Q8I5X156.11MGLACTOSE MONOHYDRATEORAL; CAPSULE, COATED, SOFT GELATIN64044515EWQ57Q8I5X178.905MGLACTOSE MONOHYDRATEORAL; CAPSULE, EXTENDED RELEASE64044515EWQ57Q8I5X23.3MGLACTOSE MONOHYDRATEORAL; CAPSULE, HARD GELATIN64044515EWQ57Q8I5X161.8MGLACTOSE MONOHYDRATEORAL; CAPSULE, SUSTAINED ACTION64044515EWQ57Q8I5X67MGLACTOSE MONOHYDRATEORAL; CAPSULE, SUSTAINED ACTION, HARD GELATIN64044515EWQ57Q8I5X18.8MGLACTOSE MONOHYDRATEORAL; DISPERSIBLE TABLET64044515EWQ57Q8I5X543.6MGLACTOSE MONOHYDRATEORAL; POWDER, FOR INHALATION64044515EWQ57Q8I5X1.25%LACTOSE MONOHYDRATEORAL; POWDER, FOR SUSPENSION6
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025年教育培训市场品牌推广策略与营销模式创新研究报告
- 2025年生态旅游可持续发展关键技术与策略分析报告
- 漳州评审管理暂行办法
- 社区矫正实施管理办法
- 税务案件检举管理办法
- 中央论坛活动管理办法
- 理财贷款管理暂行办法
- 业务评估管理办法试行
- 智能制造技术的市场应用报告
- 车辆归档资料管理办法
- 河南省天一联考2026届高三年级开学联考语文试卷(含答案解析)
- 遴选笔试真题及答案
- 2025-2026学年人教版(2024)小学美术三年级上册教学计划及进度表
- 医疗科室外包合同协议书
- 基于核心素养的中小学安全教育课程设计与实施路径
- 超级充电综合站及配套设施建设项目可行性研究报告
- 2025-2026学年统编版小学语文四年级上册教学计划及进度表
- 2025年湖北省武汉市中考语文真题(含答案)
- 中国心房颤动管理指南2025解读
- 《云计算与大数据》课件第3章“大数据”关键技术与应用
- 2025-2026学年人教大同版(2024)小学英语三年级上册教学计划及进度表
评论
0/150
提交评论